Cabinet approves PLI scheme for pharmaceuticals
The Hindu
The government on February 24 approved Production Linked Incentive (PLI) scheme for pharmaceuticals, and said the move will bring investments of ₹15,000 crore into the sector.
The scheme will benefit domestic manufacturers, spur job opportunities and contribute to availability of wider range of affordable medicines for consumers. It is expected to bring in investment of ₹15,000 crore in the pharmaceutical sector, an official release said.
More Related News

The U.S. has launched two investigations under Section 301 of the Trade Act of 1974 against India and other economies to examine practices that may be ‘unreasonable or discriminatory and burden or restrict U.S. commerce’. One probe examines whether countries, including India, are using excess manufacturing capacity to export to the U.S. in a manner that hurts American businesses, while another looks at whether countries have taken ‘sufficient steps’ to prohibit imports of goods produced with forced labour.












